Involvement of focal adhesion kinase in the progression and prognosis of gastrointestinal stromal tumors

Nobuyuki Kamo, Yoshio Naomoto, Yasuhiro Shirakawa, Tomoki Yamatsuji, Seiichi Hirota, Yasuhiro Fujiwara, Kazuhiro Noma, Kazufumi Sakurama, Munenori Takaoka, Hitoshi Nagatsuka, Mehmet Gunduz, Junji Matsuoka, Noriaki Tanaka

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Gastrointestinal stromal tumors often express gene mutations to c-KIT and platelet-derived growth factor receptor-α, both of which result in constitutive activations of their signaling pathways that are quite essential for the proliferation and survival of tumor cells in most clinical gastrointestinal stromal tumors. Targeting these molecules provides a dramatic improvement to therapeutic strategy. To identify a new therapeutic target for gastrointestinal stromal tumor treatment, we focused on focal adhesion kinase, which is reported to be an up-regulated gene in clinical gastrointestinal stromal tumors, because so far no one has examined its expression status at the protein level. In this study, Western blot analysis revealed that all 10 of the examined gastrointestinal stromal tumor tissues strongly expressed focal adhesion kinase protein and that phosphorylated focal adhesion kinase was detected in 9 of them. Next, we assessed the expression status of focal adhesion kinase and phosphorylated focal adhesion kinase in 51 cases of gastrointestinal stromal tumor by immunohistochemistry. Positive stainings for focal adhesion kinase and phosphorylated focal adhesion kinase were confirmed in 44 (86.3%) and in 40 cases (78.4%) of the 51 gastrointestinal stromal tumors, respectively. We further found that the focal adhesion kinase-positive staining rate became higher along with the increased status of malignant behavior. Moreover, when the 51 gastrointestinal stromal tumors were divided into 2 groups based upon their focal adhesion kinase expression status, the 5-year overall survival of patients in the focal adhesion kinase-positive group (66.5%) was significantly poorer than that in the focal adhesion kinase-negative group (100%). These results indicate that the up-regulation of focal adhesion kinase protein may also contribute to the tumor progression of gastrointestinal stromal tumors and that focal adhesion kinase is a potential target for gastrointestinal stromal tumor treatment.

Original languageEnglish
Pages (from-to)1643-1649
Number of pages7
JournalHuman Pathology
Volume40
Issue number11
DOIs
Publication statusPublished - Nov 2009

Fingerprint

Focal Adhesion Protein-Tyrosine Kinases
Gastrointestinal Stromal Tumors
Staining and Labeling
Platelet-Derived Growth Factor Receptors
Proteins
Therapeutics
Genes
Neoplasms
Cell Survival

Keywords

  • FAK
  • GIST
  • Immunohistochemistry
  • Patients' outcome

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Involvement of focal adhesion kinase in the progression and prognosis of gastrointestinal stromal tumors. / Kamo, Nobuyuki; Naomoto, Yoshio; Shirakawa, Yasuhiro; Yamatsuji, Tomoki; Hirota, Seiichi; Fujiwara, Yasuhiro; Noma, Kazuhiro; Sakurama, Kazufumi; Takaoka, Munenori; Nagatsuka, Hitoshi; Gunduz, Mehmet; Matsuoka, Junji; Tanaka, Noriaki.

In: Human Pathology, Vol. 40, No. 11, 11.2009, p. 1643-1649.

Research output: Contribution to journalArticle

Kamo, N, Naomoto, Y, Shirakawa, Y, Yamatsuji, T, Hirota, S, Fujiwara, Y, Noma, K, Sakurama, K, Takaoka, M, Nagatsuka, H, Gunduz, M, Matsuoka, J & Tanaka, N 2009, 'Involvement of focal adhesion kinase in the progression and prognosis of gastrointestinal stromal tumors', Human Pathology, vol. 40, no. 11, pp. 1643-1649. https://doi.org/10.1016/j.humpath.2009.05.004
Kamo, Nobuyuki ; Naomoto, Yoshio ; Shirakawa, Yasuhiro ; Yamatsuji, Tomoki ; Hirota, Seiichi ; Fujiwara, Yasuhiro ; Noma, Kazuhiro ; Sakurama, Kazufumi ; Takaoka, Munenori ; Nagatsuka, Hitoshi ; Gunduz, Mehmet ; Matsuoka, Junji ; Tanaka, Noriaki. / Involvement of focal adhesion kinase in the progression and prognosis of gastrointestinal stromal tumors. In: Human Pathology. 2009 ; Vol. 40, No. 11. pp. 1643-1649.
@article{b5016d6e120346e495fd5cd9027ab16a,
title = "Involvement of focal adhesion kinase in the progression and prognosis of gastrointestinal stromal tumors",
abstract = "Gastrointestinal stromal tumors often express gene mutations to c-KIT and platelet-derived growth factor receptor-α, both of which result in constitutive activations of their signaling pathways that are quite essential for the proliferation and survival of tumor cells in most clinical gastrointestinal stromal tumors. Targeting these molecules provides a dramatic improvement to therapeutic strategy. To identify a new therapeutic target for gastrointestinal stromal tumor treatment, we focused on focal adhesion kinase, which is reported to be an up-regulated gene in clinical gastrointestinal stromal tumors, because so far no one has examined its expression status at the protein level. In this study, Western blot analysis revealed that all 10 of the examined gastrointestinal stromal tumor tissues strongly expressed focal adhesion kinase protein and that phosphorylated focal adhesion kinase was detected in 9 of them. Next, we assessed the expression status of focal adhesion kinase and phosphorylated focal adhesion kinase in 51 cases of gastrointestinal stromal tumor by immunohistochemistry. Positive stainings for focal adhesion kinase and phosphorylated focal adhesion kinase were confirmed in 44 (86.3{\%}) and in 40 cases (78.4{\%}) of the 51 gastrointestinal stromal tumors, respectively. We further found that the focal adhesion kinase-positive staining rate became higher along with the increased status of malignant behavior. Moreover, when the 51 gastrointestinal stromal tumors were divided into 2 groups based upon their focal adhesion kinase expression status, the 5-year overall survival of patients in the focal adhesion kinase-positive group (66.5{\%}) was significantly poorer than that in the focal adhesion kinase-negative group (100{\%}). These results indicate that the up-regulation of focal adhesion kinase protein may also contribute to the tumor progression of gastrointestinal stromal tumors and that focal adhesion kinase is a potential target for gastrointestinal stromal tumor treatment.",
keywords = "FAK, GIST, Immunohistochemistry, Patients' outcome",
author = "Nobuyuki Kamo and Yoshio Naomoto and Yasuhiro Shirakawa and Tomoki Yamatsuji and Seiichi Hirota and Yasuhiro Fujiwara and Kazuhiro Noma and Kazufumi Sakurama and Munenori Takaoka and Hitoshi Nagatsuka and Mehmet Gunduz and Junji Matsuoka and Noriaki Tanaka",
year = "2009",
month = "11",
doi = "10.1016/j.humpath.2009.05.004",
language = "English",
volume = "40",
pages = "1643--1649",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "11",

}

TY - JOUR

T1 - Involvement of focal adhesion kinase in the progression and prognosis of gastrointestinal stromal tumors

AU - Kamo, Nobuyuki

AU - Naomoto, Yoshio

AU - Shirakawa, Yasuhiro

AU - Yamatsuji, Tomoki

AU - Hirota, Seiichi

AU - Fujiwara, Yasuhiro

AU - Noma, Kazuhiro

AU - Sakurama, Kazufumi

AU - Takaoka, Munenori

AU - Nagatsuka, Hitoshi

AU - Gunduz, Mehmet

AU - Matsuoka, Junji

AU - Tanaka, Noriaki

PY - 2009/11

Y1 - 2009/11

N2 - Gastrointestinal stromal tumors often express gene mutations to c-KIT and platelet-derived growth factor receptor-α, both of which result in constitutive activations of their signaling pathways that are quite essential for the proliferation and survival of tumor cells in most clinical gastrointestinal stromal tumors. Targeting these molecules provides a dramatic improvement to therapeutic strategy. To identify a new therapeutic target for gastrointestinal stromal tumor treatment, we focused on focal adhesion kinase, which is reported to be an up-regulated gene in clinical gastrointestinal stromal tumors, because so far no one has examined its expression status at the protein level. In this study, Western blot analysis revealed that all 10 of the examined gastrointestinal stromal tumor tissues strongly expressed focal adhesion kinase protein and that phosphorylated focal adhesion kinase was detected in 9 of them. Next, we assessed the expression status of focal adhesion kinase and phosphorylated focal adhesion kinase in 51 cases of gastrointestinal stromal tumor by immunohistochemistry. Positive stainings for focal adhesion kinase and phosphorylated focal adhesion kinase were confirmed in 44 (86.3%) and in 40 cases (78.4%) of the 51 gastrointestinal stromal tumors, respectively. We further found that the focal adhesion kinase-positive staining rate became higher along with the increased status of malignant behavior. Moreover, when the 51 gastrointestinal stromal tumors were divided into 2 groups based upon their focal adhesion kinase expression status, the 5-year overall survival of patients in the focal adhesion kinase-positive group (66.5%) was significantly poorer than that in the focal adhesion kinase-negative group (100%). These results indicate that the up-regulation of focal adhesion kinase protein may also contribute to the tumor progression of gastrointestinal stromal tumors and that focal adhesion kinase is a potential target for gastrointestinal stromal tumor treatment.

AB - Gastrointestinal stromal tumors often express gene mutations to c-KIT and platelet-derived growth factor receptor-α, both of which result in constitutive activations of their signaling pathways that are quite essential for the proliferation and survival of tumor cells in most clinical gastrointestinal stromal tumors. Targeting these molecules provides a dramatic improvement to therapeutic strategy. To identify a new therapeutic target for gastrointestinal stromal tumor treatment, we focused on focal adhesion kinase, which is reported to be an up-regulated gene in clinical gastrointestinal stromal tumors, because so far no one has examined its expression status at the protein level. In this study, Western blot analysis revealed that all 10 of the examined gastrointestinal stromal tumor tissues strongly expressed focal adhesion kinase protein and that phosphorylated focal adhesion kinase was detected in 9 of them. Next, we assessed the expression status of focal adhesion kinase and phosphorylated focal adhesion kinase in 51 cases of gastrointestinal stromal tumor by immunohistochemistry. Positive stainings for focal adhesion kinase and phosphorylated focal adhesion kinase were confirmed in 44 (86.3%) and in 40 cases (78.4%) of the 51 gastrointestinal stromal tumors, respectively. We further found that the focal adhesion kinase-positive staining rate became higher along with the increased status of malignant behavior. Moreover, when the 51 gastrointestinal stromal tumors were divided into 2 groups based upon their focal adhesion kinase expression status, the 5-year overall survival of patients in the focal adhesion kinase-positive group (66.5%) was significantly poorer than that in the focal adhesion kinase-negative group (100%). These results indicate that the up-regulation of focal adhesion kinase protein may also contribute to the tumor progression of gastrointestinal stromal tumors and that focal adhesion kinase is a potential target for gastrointestinal stromal tumor treatment.

KW - FAK

KW - GIST

KW - Immunohistochemistry

KW - Patients' outcome

UR - http://www.scopus.com/inward/record.url?scp=70349882107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349882107&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2009.05.004

DO - 10.1016/j.humpath.2009.05.004

M3 - Article

VL - 40

SP - 1643

EP - 1649

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 11

ER -